Summary
The fund seeks capital appreciation by investing in large-size companies in the United States.
The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team uses a proprietary screening tool to identify investable opportunities.
The fundamental research focuses on companies with sustainable competitive advantages, key profit drivers, and cash generation capacity.
Next, the research team emphasizes companies with improving quality metrics, business momentu
Link
Directors
Jan 12, 2024- Paul L. Rosenberg
- James E. Davey
- Andrew A. Johnson
- Robin C. Beery
- Derrick D. Cephas
- Hilary E. Ackermann
- Christine R. Detrick
- David Sung
- John J. Gauthier
Chief Compliance Officer
- Joseph G. Melcher
Fund Manager(s)
- Mammen Chally
- Douglas McLane
- David Siegle
Price
Company Name |
Holding |
| Salesforce Inc | 1.07 % |
| Progressive Corp/The | 0.99 % |
| Vertex Pharmaceuticals Inc | 0.92 % |
| Welltower Inc | 0.89 % |
| Accenture PLC | 0.88 % |
| AMETEK Inc | 0.86 % |
| More |
Documents
Performance
YTD
9.8%
3 Year
13.95%
5 Year
68.23%
Best
30.26%
2019
Worst
-21.84%
2022
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 12.1% | 5.4% | -6.5% | 4.6% | -19.5% | 13.6% | 1.1% | 6.2% | -0.1% | - |
| Q2 | -1.9% | 7% | -15.2% | 7.7% | 19.1% | 4.5% | 4.8% | 3.7% | 2.4% | 1.4% |
| Q3 | - | -3.6% | -4.2% | -2.9% | 8.9% | 1.7% | 7.2% | 2.9% | 1.4% | -4% |
| Q4 | - | 8.3% | 2.9% | 10.2% | 12.5% | 6.2% | -12.3% | 7.3% | 1.9% | 6.4% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.5% | 6.1% | 3% | -3.5% | - | - | - | - | - | - | - | - |
| 2023 | 5.3% | -3.5% | 3.7% | 1.5% | -0.3% | 5.6% | 2.8% | -1.4% | -4.9% | -1% | 8.4% | 1% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10% | 18% | -22% | 21% | 18% | 30% | -2% | 22% | 6% | 0% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| HGIIX | 10% | 18% | -22% | 21% | 18% | 30% | -2% | 22% | 6% | - |
| Russell 1000 Index | - | - | -19% | 25% | 19% | 29% | -7% | 19% | 10% | -1% |
| Alpha | 10% | 18% | -3% | -4% | -1% | 1% | 5% | 3% | -4% | - |